Y. Yildiz Et Al. , "Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors," ONCOTARGETS AND THERAPY , vol.9, pp.5809-5817, 2016
Yildiz, Y. Et Al. 2016. Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors. ONCOTARGETS AND THERAPY , vol.9 , 5809-5817.
Yildiz, Y., SÖKMENSÜER, C., & YALÇIN, Ş., (2016). Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors. ONCOTARGETS AND THERAPY , vol.9, 5809-5817.
Yildiz, Yetkin, CENK SÖKMENSÜER, And ŞUAYİB YALÇIN. "Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors," ONCOTARGETS AND THERAPY , vol.9, 5809-5817, 2016
Yildiz, Yetkin Et Al. "Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors." ONCOTARGETS AND THERAPY , vol.9, pp.5809-5817, 2016
Yildiz, Y. SÖKMENSÜER, C. And YALÇIN, Ş. (2016) . "Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors." ONCOTARGETS AND THERAPY , vol.9, pp.5809-5817.
@article{article, author={Yetkin Yildiz Et Al. }, title={Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors}, journal={ONCOTARGETS AND THERAPY}, year=2016, pages={5809-5817} }